3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Breast Cancer -

Silicone breast implants given the OK by the FDA

Breast CancerNov 21, 06

The Food and Drug Administration (FDA) in the U.S. has lifted a ban on the use of silicone breast implants.

But the removal of the 14 year ban carries the proviso that the implants be studied for side effects on 40,000 women for a 10 year period.

The FDA says a number of independent studies have failed to find evidence that the silicone breast implants caused tissue damage or cancer, but nevertheless safety concerns continue to worry some.

The breast implants were banned for the majority of American women in 1992 after complaints that the devices leaked and accusations that the leaking silicone made some women ill, but they remained legal in Britain.

The FDA says there still exists a risk of complications such as breast pain and implant rupture and that many silicone implants will eventually need to be removed or replaced and the women would probably need surgery again.

Advocates for the silicone implants say they look and feel more natural than those filled with salt water and cosmetic surgeons believe they will be the first choice for the 300,000 American women a year who opt for breast enlargement.

The news has been welcomed by many plastic surgeons who say the newer silicone implants are safer and the lifting of the U.S. ban will remove any lingering doubts about the safety of breast implants.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Fat grafting technique improves results of breast augmentation
  UW research shows sensor technology may help improve accuracy of clinical breast exams
  Generic Breast Cancer Drugs Boost Adherence
  New models of drug-resistant breast cancer point to better treatments
  Breast tomosynthesis increases cancer detection and reduces recall rates
  2 views are better than 1 in 3-D breast screening
  Study reveals genomic similarities between breast cancer and ovarian cancers
  Moderate exercise tied to lower breast cancer risk
  Risk for some cancers rises with U.S. obesity rate
  New genomic test spares patients chemotherapy with no adverse effect on survival
  Breast Cancer In Black Women Is A Different Disease
  Combination of Everolimus and Exemestane Improves Progression-Free Survival for Women with Metastatic Breast Cancer

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site